FAAH Inhibition Reverses Depressive-like Behavior and Sex-Specific Neuroinflammatory Alterations Induced by Early...

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Early life stress (ELS) is a significant risk factor for major depressive disorder (MDD).
• Neuroinflammation plays a critical role in the development of MDD following ELS.
• Fatty acid amide hydrolase (FAAH) is a key enzyme in the endocannabinoid system, modulating inflammatory responses.

Purpose of the Study:

• To investigate the long-term effects of the FAAH inhibitor URB597 on ELS-induced depressive-like behavior in rats.
• To examine the impact of URB597 on the gene expression of pro-inflammatory cytokines in the medial prefrontal cortex (mPFC) and CA1 regions following ELS.
• To determine if these gene expression changes emerge during late adolescence.

Main Methods:

• Induction of ELS in adult male and female rats.
• Administration of URB597 to assess behavioral and molecular changes.
• Measurement of depressive-like behavior using established behavioral paradigms.
• Quantitative analysis of messenger RNA (mRNA) levels for pro-inflammatory cytokines (e.g., IL-6, TNF-α, IL-1β, CRF) and NF-κB1 in the mPFC and CA1.

Main Results:

• ELS induced depressive-like behaviors in adult rats, which were ameliorated by URB597 treatment.
• URB597 normalized sex-specific alterations in nfκb1, il6, il1β, and tnfα gene expression in the mPFC and CA1.
• Some observed gene expression changes were already present in late adolescence, indicating early molecular alterations.

Conclusions:

• URB597 demonstrates therapeutic potential for reversing ELS-induced depressive-like behaviors.
• The therapeutic effects of URB597 are associated with modulation of neuroinflammatory cytokine gene expression.
• Significant sex differences exist in the molecular mechanisms underlying ELS-induced depression and the response to URB597.